Literature DB >> 9559785

Accumulation of norfloxacin by Mycobacterium aurum and Mycobacterium smegmatis.

K J Williams1, G A Chung, L J Piddock.   

Abstract

The modified fluorescence method was used to determine the accumulation of norfloxacin by Mycobacterium aurum A+ and Mycobacterium smegmatis mc(2)155. By using an exogenous norfloxacin concentration of 10 microg/ml, a steady-state concentration (SSC) of 160 to 180 ng of norfloxacin/mg of cells was obtained for M. aurum, and an SSC of 120 to 140 ng of norfloxacin/mg of cells obtained for M. smegmatis. For both species of mycobacteria, the SSC was achieved within 5 min. The silicon oil method was investigated and gave higher SSCs than the modified fluorescence method. Further studies on the mechanism of norfloxacin accumulation by M. aurum were performed. An increase in the pH of the wash buffer from 7.0 to 9.0 did not significantly affect the final SSC obtained. Accumulation was nonsaturated over a norfloxacin concentration range of 0 to 100 microg/ml, and the proton motive force inhibitor 2,4-dinitrophenol (1 and 2 mM), whether it was added before or after norfloxacin was added, had no effect on the final SSC obtained. 2,4-Dinitrophenol also had no effect on norfloxacin accumulation by M. smegmatis. Furthermore, norfloxacin accumulation by M. aurum was unaffected by the presence of either Tween 80 or subinhibitory concentrations of ethambutol in the growth medium. Therefore, it is proposed that norfloxacin accumulation by mycobacteria occurs by simple, energy-independent diffusion.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9559785      PMCID: PMC105544          DOI: 10.1128/AAC.42.4.795

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  39 in total

1.  In vitro and in vivo activities of sparfloxacin (AT-4140) against Mycobacterium tuberculosis.

Authors:  B Ji; C Truffot-Pernot; J Grosset
Journal:  Tubercle       Date:  1991-09

2.  ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyrase A subunit in forming resistance phenotype.

Authors:  R Muñoz; A G De La Campa
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

3.  Effects of colonial morphology and tween 80 on antimicrobial susceptibility of Mycobacterium paratuberculosis.

Authors:  R M Van Boxtel; R S Lambrecht; M T Collins
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

4.  Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacin.

Authors:  E Cambau; W Sougakoff; M Besson; C Truffot-Pernot; J Grosset; V Jarlier
Journal:  J Infect Dis       Date:  1994-08       Impact factor: 5.226

5.  Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra.

Authors:  T Kocagöz; C J Hackbarth; I Unsal; E Y Rosenberg; H Nikaido; H F Chambers
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

Review 6.  Mode of action of the new quinolones: new data.

Authors:  D C Hooper; J S Wolfson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

7.  Intracellular accumulation of norfloxacin in Mycobacterium smegmatis.

Authors:  S Corti; J Chevalier; A Cremieux
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

Review 8.  The envelope of mycobacteria.

Authors:  P J Brennan; H Nikaido
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

9.  Powerful bactericidal activity of sparfloxacin (AT-4140) against Mycobacterium tuberculosis in mice.

Authors:  V Lalande; C Truffot-Pernot; A Paccaly-Moulin; J Grosset; B Ji
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

10.  Characterization of fluoroquinolone-resistant mutant strains of Mycobacterium tuberculosis selected in the laboratory and isolated from patients.

Authors:  G J Alangaden; E K Manavathu; S B Vakulenko; N M Zvonok; S A Lerner
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

View more
  2 in total

1.  Transformation of the antibacterial agent norfloxacin by environmental mycobacteria.

Authors:  Michael D Adjei; Thomas M Heinze; Joanna Deck; James P Freeman; Anna J Williams; John B Sutherland
Journal:  Appl Environ Microbiol       Date:  2006-09       Impact factor: 4.792

2.  Distribution of fluoroquinolones in the two aqueous compartments of Escherichia coli.

Authors:  Ankit Pandeya; Olaniyi Alegun; Yuguang Cai; Yinan Wei
Journal:  Biochem Biophys Rep       Date:  2020-11-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.